Biosimilar Newsletter Archive

1. 09.26.23 -- Optimize Your Cell Line Preparation 9/26/2023

   09/26/23 Biosimilar Development Newsletter

2. 09.25.23 -- Improve Your Productivity With The Use Of Effective Modular Systems 9/25/2023

   09/25/23 Biosimilar Development Newsletter

3. 09.21.23 -- De-Risking Biosimilar Development With A Clinically Validated And Commercially Proven Disposable Autoinjector 9/21/2023
   09/21/23 Biosimilar Development Newsletter
4. 09.14.23 -- Biosimilars Forum Statement On CMS Announcement Of Drug Negotiation List 9/14/2023
   09/14/23 Biosimilar Development Newsletter
5. 09.13.23 -- Affinity Chromatography For mAbs, Mechanistic Modeling, And Polishing 9/13/2023
   09/13/23 Biosimilar Development Newsletter
6. 09.07.23 -- FDA Approves First Biosimilar To Treat MS 9/7/2023
   09/07/23 Biosimilar Development Newsletter
7. 08.31.23 -- The Cancer Drug Shortage: When Quality Fails 8/31/2023
   08/31/23 Biosimilar Development Newsletter
8. 08.30.23 -- Futureproof The Design Of Your Biomanufacturing Capacity 8/30/2023

   08/30/23 Biosimilar Development Newsletter

9. 08.24.23 -- Key Post-Pandemic Trends In Global FDA Facility Observations 8/24/2023
   08/24/23 Biosimilar Development Newsletter
10. 08.23.23 -- Mitigating Particulate Risk For Your Injectable Drug Product 8/23/2023

    08/23/23 Biosimilar Development Newsletter